You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 9,169,212


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,169,212
Title:Azepane derivatives and methods of treating hepatitis B infections
Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
Inventor(s): Hartman; George D. (Lansdale, PA), Kuduk; Scott (Harleysville, PA)
Assignee: Novira Therapeutics, Inc. (Doylestown, PA)
Application Number:14/511,964
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Understanding the Scope and Claims of United States Patent 9,169,212: A Comprehensive Analysis

Introduction

Patents are a cornerstone of intellectual property law, providing inventors and innovators with exclusive rights to their creations. The United States Patent 9,169,212, like any other patent, is a complex document that outlines the scope and claims of an invention. This article delves into the key aspects of this patent, including its claims, the patent landscape, and relevant legal frameworks.

What is a Patent?

Before diving into the specifics of the patent in question, it is essential to understand what a patent is. A patent is a form of intellectual property that grants the holder the exclusive right to make, use, sell, offer to sell, or import the invention for a limited period of time, typically 20 years from the filing date of the patent application[4].

The Patent Claims Research Dataset

To analyze patent claims effectively, researchers often rely on datasets provided by the USPTO. The Patent Claims Research Dataset, for example, contains detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset helps in understanding the structure and scope of patent claims, including dependency relationships between claims[3].

The Structure of Patent Claims

Patent claims are the heart of a patent, as they define the scope of the invention. Claims must "particularly point out and distinctly claim the subject matter which the applicant regards as his invention"[2]. This means that the claims, when read in light of the specification and prosecution history, must inform those skilled in the art about the scope of the invention with reasonable certainty.

Claim Types

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Multiple Dependent Claims: These claims refer back to more than one preceding claim.

Claim Requirements

For a claim to be valid, it must meet several requirements:

  • Definiteness: The claim must be clear and distinct, informing those skilled in the art about the scope of the invention[2].
  • Enablement: The specification must provide sufficient information to enable a person skilled in the art to make and use the invention.
  • Written Description: The specification must contain a written description of the invention that supports the claims.

United States Patent 9,169,212: An Overview

Patent Details

  • Patent Number: 9,169,212
  • Grant Date: This information is not provided in the sources, but it can be found through the USPTO database.
  • Inventor(s) and Assignee: Similarly, this information would be available through the USPTO database.

Claims Analysis

To analyze the claims of this patent, one would need to review the patent document itself. Here are some general steps to follow:

Independent Claims

  • Identify the independent claims, which typically define the broadest scope of the invention.
  • Analyze these claims to understand the core elements of the invention.

Dependent Claims

  • Review the dependent claims to see how they further limit the independent claims.
  • Understand how these claims add specificity and detail to the invention.

Scope of the Invention

The scope of the invention is defined by the claims. Here, you would need to:

  • Identify the key elements of the invention as described in the claims.
  • Determine how these elements interact to form the overall invention.

Patent Landscape and Related Patents

Continuations and Continuations-in-Part

Patents can be part of a larger family, including continuations and continuations-in-part. For example, in the case of Cellect, LLC, several patents were continuations-in-part of earlier patents, which affected their patent term adjustments and potential for obviousness-type double patenting[1].

Inter Partes Review (IPR)

The patent landscape also includes post-grant proceedings such as Inter Partes Review (IPR), established by the Leahy-Smith America Invents Act (AIA). IPR allows for the challenge of patent validity after the patent has been granted, which can impact the scope and claims of a patent[4].

Legal Frameworks and Challenges

Obviousness-Type Double Patenting (ODP)

ODP is a doctrine that prevents the extension of patent term by claiming the same invention in multiple patents. This was a key issue in the Cellect, LLC case, where claims were found to be unpatentable over earlier patents in the same family[1].

Indefiniteness

Claims that are indefinite, meaning they do not clearly define the scope of the invention, can be invalidated. The standard for indefiniteness requires clear and convincing evidence that the claims fail to inform those skilled in the art about the scope of the invention[2].

Patent Subject Matter Eligibility

The AIA and subsequent guidelines have clarified what subject matter is eligible for patenting. The Alice/Mayo test is used to determine if a patent claim is directed to ineligible subject matter, such as laws of nature, natural phenomena, or abstract ideas. If so, the claim must have an "inventive concept" to be patentable[4].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court, which could simplify and reduce the costs associated with patent litigation. This could potentially impact how patent claims are enforced and challenged, especially for smaller inventors and businesses[5].

Key Takeaways

  • Patent Claims: The heart of a patent, defining the scope of the invention.
  • Definiteness and Enablement: Claims must be clear and enable those skilled in the art to make and use the invention.
  • Patent Landscape: Includes continuations, IPR, and other post-grant proceedings that can affect patent validity.
  • Legal Frameworks: ODP, indefiniteness, and subject matter eligibility are crucial in determining the validity of patent claims.
  • Small Claims Court: Potential future developments that could simplify patent litigation.

FAQs

What is the purpose of patent claims?

Patent claims define the scope of the invention and are crucial for determining what is protected by the patent.

How are patent claims structured?

Patent claims include independent claims that stand alone and dependent claims that refer back to and further limit independent claims.

What is obviousness-type double patenting (ODP)?

ODP is a doctrine that prevents the extension of patent term by claiming the same invention in multiple patents.

What is the significance of the Alice/Mayo test in patent law?

The Alice/Mayo test is used to determine if a patent claim is directed to ineligible subject matter and whether it contains an "inventive concept" to be patentable.

Why is definiteness important in patent claims?

Definiteness ensures that the claims clearly define the scope of the invention, informing those skilled in the art with reasonable certainty.

Sources

  1. In re Cellect, LLC, United States Court of Appeals for the Federal Circuit, August 28, 2023.
  2. Maxell, Ltd. v. Amperex Technology Limited, United States Court of Appeals for the Federal Circuit, March 6, 2024.
  3. Patent Claims Research Dataset, USPTO, August 28, 2017.
  4. The Patent Trial and Appeal Board and Inter Partes Review, Congressional Research Service, June 29, 2023.
  5. U.S. Patent Small Claims Court, Administrative Conference of the United States, April 28, 2022.

More… ↓

⤷  Subscribe

Details for Patent 9,169,212

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Llc RECOMBIVAX, RECOMBIVAX HB hepatitis b vaccine (recombinant) Injection 101066 July 23, 1986 ⤷  Subscribe 2034-01-16
Glaxosmithkline Biologicals ENGERIX-B hepatitis b vaccine (recombinant) Injection 103239 August 28, 1989 ⤷  Subscribe 2034-01-16
Pharmaand Gmbh PEGASYS peginterferon alfa-2a Injection 103964 October 16, 2002 ⤷  Subscribe 2034-01-16
Pharmaand Gmbh PEGASYS peginterferon alfa-2a Injection 103964 January 07, 2004 ⤷  Subscribe 2034-01-16
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.